Metropolis Healthcare Ltd
NSE:METROPOLIS
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
1 503.8
2 288
|
Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one METROPOLIS stock under the Base Case scenario is 1 440.76 INR. Compared to the current market price of 2 061.85 INR, Metropolis Healthcare Ltd is Overvalued by 30%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Metropolis Healthcare Ltd
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for METROPOLIS cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Metropolis Healthcare Ltd
Balance Sheet Decomposition
Metropolis Healthcare Ltd
Current Assets | 3.2B |
Cash & Short-Term Investments | 1.3B |
Receivables | 1.3B |
Other Current Assets | 589.7m |
Non-Current Assets | 12.4B |
Long-Term Investments | 265.2m |
PP&E | 3.4B |
Intangibles | 8.4B |
Other Non-Current Assets | 356.5m |
Current Liabilities | 2.5B |
Accounts Payable | 994.4m |
Accrued Liabilities | 104.8m |
Other Current Liabilities | 1.4B |
Non-Current Liabilities | 2.1B |
Long-Term Debt | 1.2B |
Other Non-Current Liabilities | 939.7m |
Earnings Waterfall
Metropolis Healthcare Ltd
Revenue
|
12.4B
INR
|
Cost of Revenue
|
-2.6B
INR
|
Gross Profit
|
9.8B
INR
|
Operating Expenses
|
-7.8B
INR
|
Operating Income
|
2B
INR
|
Other Expenses
|
-623m
INR
|
Net Income
|
1.4B
INR
|
Free Cash Flow Analysis
Metropolis Healthcare Ltd
INR | |
Free Cash Flow | INR |
METROPOLIS Profitability Score
Profitability Due Diligence
Metropolis Healthcare Ltd's profitability score is 60/100. The higher the profitability score, the more profitable the company is.
Score
Metropolis Healthcare Ltd's profitability score is 60/100. The higher the profitability score, the more profitable the company is.
METROPOLIS Solvency Score
Solvency Due Diligence
Metropolis Healthcare Ltd's solvency score is 71/100. The higher the solvency score, the more solvent the company is.
Score
Metropolis Healthcare Ltd's solvency score is 71/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
METROPOLIS Price Targets Summary
Metropolis Healthcare Ltd
According to Wall Street analysts, the average 1-year price target for METROPOLIS is 2 163.42 INR with a low forecast of 1 707.91 INR and a high forecast of 2 782.5 INR.
Dividends
Current shareholder yield for METROPOLIS is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
METROPOLIS Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Metropolis Healthcare Ltd. owns and operates medical laboratories. The company is headquartered in Gurgaon, Haryana and currently employs 4,532 full-time employees. The company went IPO on 2019-04-15. The firm offers a range of clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and monitoring of the disease. The firm also offers analytical and support services to clinical research organizations for their clinical research projects. Its services include pathology testing services, corporate wellness, lab in hospitals and clinical research services. The firm offers a range of tests and profiles that include advanced tests in diagnosis of cancer, neurological disorders, infectious diseases, and an array of genetic abnormalities. The company owns a chain of diagnostic centers across India, South Asia, Africa and the Middle East. The firm has spread its footprint across 20 Indian states and over 210 cities.
Contact
IPO
Employees
Officers
The intrinsic value of one METROPOLIS stock under the Base Case scenario is 1 440.76 INR.
Compared to the current market price of 2 061.85 INR, Metropolis Healthcare Ltd is Overvalued by 30%.